Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-25-003137
Filing Date
2025-08-13
Accepted
2025-08-13 14:38:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5049
  Complete submission text file 0001172661-25-003137.txt   6920
Mailing Address LEVEL 1 10 PORTMAN SQUARE LONDON X0 W1H6AZ
Business Address LEVEL 1 10 PORTMAN SQUARE LONDON X0 W1H6AZ 442074959070
Independent Franchise Partners LLP (Filed by) CIK: 0001483866 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231

Mailing Address C/O 3M COMPANY 3M CENTER, BUILDING 275-6W-02 ST. PAUL MN 55144-1000
Business Address C/O 3M COMPANY 3M CENTER, BUILDING 275-6W-02 ST. PAUL MN 55144-1000 651-733-1110
Solventum Corp (Subject) CIK: 0001964738 (see all company filings)

EIN.: 922008841 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94660 | Film No.: 251210718
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)